Unmasking Fracture Risk in Type 2 Diabetes: The Association of Longitudinal Glycemic Hemoglobin Level and Medications.

Bowen WangZehai WangAtharva A PoundarikMohammed J ZakiRichard S BockmanBenjamin S GlicksbergGirish N NadkarniDeepak Vashishth

Published in: The Journal of clinical endocrinology and metabolism (2021)

Longitudinal two-year HbA1c is independently associated with an elevated all fracture risk in T2D individuals during a two-year follow-up period. Metformin and DPP4 inhibitors can be used for management of T2D fracture risk.

Keyphrases

type diabetes
cross sectional
cardiovascular disease
glycemic control
insulin resistance